Effects of renal insufficiency and aging on the pharmacokinetics of a phenethylamine class α(1A)-adrenoceptor agonist NS-49

International Journal of Pharmaceutics

Volumn 185, Issue 1, 1999, Pages 37-43

  Mukai, Hideya ^a   Morino, Akira ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

Aging; NS 49; Rat; Renal excretion; Renal insufficiency

Indexed keywords

3' (2 AMINO 1 HYDROXYETHYL) 4' FLUOROMETHANESULFONANILIDE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT;

AGING; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-AGONISTS; AGING; ANILIDES; ANIMALS; AREA UNDER CURVE; CREATININE; GLOMERULAR FILTRATION RATE; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032782282     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00142-8     Document Type: Article

References (19)

1. Dawling S., Crome P. Clinical pharmacokinetic considerations in the elderly An update. Clin. Pharmacokinet. 17:1989;236-263.
2. Ewy G., Kapadia G., Yao L., Lullin M., Marcus F. Digoxin metabolism in the elderly. Circulation. 39:1969;449-453.
3. Knochel J.P., Selden D.W. The Kidney. Brenner B.M., Rector F.C., Saunders W.B The Kidney. 1981;21-38.
4. 14C-L-DOPS in rats. Xenobio. Metabol. Dispos. 2:1987;519-529.
5. 14C-NS-49. Arzneim.-Forsch./Drug Res. (in press).
6. 14C-NS-49. Arzneim.-Forsch./Drug Res. 49, 434-440.
7. 1A-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;2.
8. Nielsen K.S., Hansen M.J., Kampmann J. Rapid evaluation of creatinine clearance. Lancet. 1:1971;1133-1134.
9. Novak L.P. Aging, total body potassium, fat free mass and cell mass in males and females between the ages of 18 and 85 years. J. Gerontol. 27:1972;438-443.
10. 1A-adrenoceptors. Eur. J. Pharmacol. 291:1995;327-334.
11. Ormrod D., Miller T. Experimental uremia. Nephron. 26:1980;249-254.
12. Schmucker D. Age-related changes in drug disposition. Pharmacol. Rev. 30:1979;445-456.
13. Schmucker D. Aging and drug disposition: an update. Pharmacol. Rev. 37:1985;133-148.
14. Shock N.W., Yiengst M.J., Watkin D.M. Age changes in body water and its relationship to basal oxygen consumption in males. J. Gerontol. 8:1953;388.
15. Shono F., Ito M., Mizuno Y., Nakatsuka I., Yoshitake A. Pharmacokinetic studies of L-DOPS (L-threo-3,4-Dibydroxyphenyl-serine) in renal failure rats. Xenobio. Metabol. and Dispos. 9:1994;809-819.
16. Sterner G. Experimental chronic renal failure in rats. Nephron. 24:1979;207-208.
17. 1A-adrenoceptor agonist, selectively increases intraurethral pressure in dogs. Eur. J. Pharmacol. 318:1996;117-122.
18. Taniguchi N., Ukai Y., Tanaka T., Yano J., Kimura K., Moriyama N., Kawabe K. Identification of alpha 1-adrenoceptor subtypes in the human prostatic urethra. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;412-416.
19. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:1981;879-885.